Autres langues Genflow Biosciences plc

Actions

Marché Fermé - London S.E. Autres places de cotation 17:35:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
2,25 ^GBX	0,00 %		-6,25 %	+57,89 %

27/06	Genflow Biosciences plc annonce le renforcement de ses efforts précliniques	CI
12/06	RÉSULTATS ET TRANSACTIONS : La perte de Distil se creuse ; Genflow se félicite de l'octroi d'une subvention	AN

Genflow Biosciences : Print of Ordinary and Special Resolutions	28/06
EARNINGS AND TRADING: Shuka Minerals loss narrows; Atome loss widens	27/06
Genflow Biosciences plc Announces Strengthening of Pre-Clinical Efforts	27/06
EARNINGS AND TRADING: Distil loss widens; Genflow welcomes grant	12/06
Genflow Biosciences receives 50% of grant for sarcopenia project	30/05
Genflow Biosciences Secures Grant for Sarcopenia Research Program	30/05
Genflow Biosciences advances three major programs in fight against ageing diseases	09/05
Home REIT cuts borrowings, Genflow shares restored	08/05
Genflow Biosciences Resumes London Trading	08/05
EARNINGS AND TRADING: Solid State and MTI Wireless win deals	07/05
Genflow Biosciences plc Reports Earnings Results for the Full Year Ended December 31, 2023	07/05
Genflow Biosciences to Temporarily Halt Trading Amid Delay in FY23 Results Publication	01/05
Genflow Biosciences attracts new institutional investors with £715,000 fundraise	08/04
Northcoders launches bootcamp; Schroder invests	04/04
Genflow Biosciences Raises New Funds for Liver Disease Treatment Trials	04/04
Genflow confirms publication of European patent for SIRT6	21/03
Genflow Biosciences Plc to Present Live at the Virtual Life Science Investor Forum March 7th	05/03
Genflow Biosciences Releases 2023 Year-End Review and Highlights Key Priorities for 2024	07/02
Genflow wins new research grants; Seeen margin rises	01/02
Genflow Biosciences Releases 2023 Year-End Review and Highlights Key Priorities for 2024	01/02

Aucun résultat pour cette recherche